Consil® bioactive glass particles enhance osteoblast proliferation and maintain extracellular matrix production in vitro
Article first published online: 16 NOV 2007
DOI: 10.1002/jbm.a.31669
Copyright © 2007 Wiley Periodicals, Inc.
Issue
1552-4965/asset/cover.gif?v=1&s=011c87cf5752a576bd0f779f7aac1276867c523a)
Journal of Biomedical Materials Research Part A
Volume 86A, Issue 3, pages 678–684, 1 September 2008
Additional Information
How to Cite
Au, A. Y., Au, R. Y., Al-Talib, T. K., Eves, B. and Frondoza, C. G. (2008), Consil® bioactive glass particles enhance osteoblast proliferation and maintain extracellular matrix production in vitro. Journal of Biomedical Materials Research Part A, 86A: 678–684. doi: 10.1002/jbm.a.31669
Publication History
- Issue published online: 16 JUL 2008
- Article first published online: 16 NOV 2007
- Manuscript Accepted: 20 JUL 2007
- Manuscript Revised: 19 JUL 2007
- Manuscript Received: 14 DEC 2006
Funded by
- Nutramax Laboratories, Inc.
- Abstract
- Article
- References
- Cited By
Keywords:
- osteoblasts;
- bioactive glass;
- extracellular matrix;
- bone graft;
- bone;
- cell culture
Abstract
Bioactive glasses are used clinically as bone implant materials as they are able to bond directly with bone. Studies in dogs have demonstrated the utility of Consil® Bioglass® synthetic bone graft particulate, a commercially available bioactive glass formulation, as a bone substitute for repair of bony defects. We evaluated the effect of Consil particles (500 μg/mL) on osteoblast proliferation and extracellular matrix (ECM) production at the cellular level in vitro. An osteoblast surrogate MG-63 cell line was incubated with Consil particles or medium alone for different time periods to determine the effect of Consil particles on proliferation and expression of ECM components. Osteoblasts remained viable and proliferated upon exposure to the particles, as shown by increased total DNA content. Cells incubated with Consil particles maintained expression levels of phenotype markers (type I collagen, osteocalcin, proteoglycans, and alkaline phosphatase) similar to control cells. Levels of secreted type I collagen and osteocalcin were time-dependent and similar to controls. This study verified the ability of Consil particles to enhance proliferation of osteoblast-like cells. The particles also maintained ECM production up to 21 days in culture. Our study supports the reported clinical utility of Consil particles for the repair of bony defects. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res, 2008

1552-4965/asset/olbannerleft.jpg?v=1&s=343c79177ba7ba4a14e83022a135a85fff60897a)
1552-4965/asset/olbannerright.jpg?v=1&s=692ae6cfb9620aaa8486b8867aa2cc1f34ef54b2)